Cargando…
1425. Revisiting β-Lactams for Treatment of Uncomplicated Urinary Tract Infections: Evaluation of Twice-daily Cephalexin for Empiric Treatment of UTIs
BACKGROUND: Current IDSA guidelines for the treatment of UTIs discourage oral β-lactams based on lack of adequately powered studies to assess efficacy compared to fluoroquinolones or TMP-SMX. However, increasing E. coli and Klebsiella spp. resistance to first-line antibiotics has necessitated the ne...
Autores principales: | Benning, Molly, Acosta, Dominic, Sarangarm, Preeyaporn, Walraven, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643744/ http://dx.doi.org/10.1093/ofid/ofab466.1617 |
Ejemplares similares
-
296. IV-to-PO Antibiotic Step-down Therapy for Treatment of Uncomplicated Streptococcal Bloodstream Infections
por: Ramos-Otero, Gerardo P, et al.
Publicado: (2020) -
1453. Cephalexin and Cefadroxil Are Not Therapeutic Equivalents for Uncomplicated Cystitis (uUTI): Further Analysis of Cefazolin Surrogate Susceptibility Testing Criteria
por: Jones, Ronald N, et al.
Publicado: (2019) -
278. Comparison of Oral Cephalexin Versus Oral Levofloxacin for Treatment of Uncomplicated Enterobacterales Bacteremia
por: Leung, Thomas H, et al.
Publicado: (2020) -
Treatment of uncomplicated UTI in males: a systematic review of the literature
por: Farrell, Karen, et al.
Publicado: (2021) -
Acute Uncomplicated UTI and E. coli Resistance: Implications for First-Line Empirical Antibiotic Therapy
por: Perfetto, Eleanor M,, et al.
Publicado: (2004)